-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2021 to 2023.
- Tarsus Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $868K, a 46.4% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $2.88M, a 71.9% increase from 2022.
- Tarsus Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $1.68M.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)